2,833
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin

, , , , , & show all
Pages 1874-1889 | Received 02 Feb 2021, Accepted 27 Apr 2021, Published online: 02 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sébastien Relier, Eric Rivals & Alexandre David. (2022) The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells. RNA Biology 19:1, pages 132-142.
Read now
XiaoJing Chen, Yite Xue, Lingfang Wang, Yang Weng, Sen Li, Weiguo Lü, Xing Xie & Xiaodong Cheng. (2022) Lectin galactoside-binding soluble 3 binding protein mediates methotrexate resistance in choriocarcinoma cell lines. Bioengineered 13:2, pages 2076-2086.
Read now
Feng Xiao & Jianrong Zhou. (2021) RETRACTED ARTICLE: FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma. Pharmacogenomics and Personalized Medicine 14, pages 1239-1245.
Read now
XiangRong Luo, JianTao She, Tao Xu, Yuan Zhou, ChuanBo Xu, JianPing Jiang, TianGang Li, Huajiang Liu, Hui Shen, Bolong Yin & Bin Dai. (2021) Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast. Bioengineered 12:2, pages 11578-11585.
Read now

Articles from other publishers (11)

Xue Chen, Ying Wang, Jia-Nan Wang, Yi-Chen Zhang, Ye-Ran Zhang, Ru-Xu Sun, Bing Qin, Yuan-Xin Dai, Hong-Jing Zhu, Jin-Xiang Zhao, Wei-Wei Zhang, Jiang-Dong Ji, Song-Tao Yuan, Qun-Dong Shen & Qing-Huai Liu. (2024) Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. EMBO Molecular Medicine 16:2, pages 294-318.
Crossref
Chendong Fu, Xianting Li, Lang Han, Ming Xie & Shurui Ouyang. (2022) LncRNA PTPRG-AS1 maintains stem-cell-like features and promotes oxaliplatin resistance in colorectal cancer via regulating the miR-665 and STAT3 axis. Molecular & Cellular Toxicology 20:1, pages 35-45.
Crossref
Kai Lin, Endi Zhou, Ting Shi, Siqing Zhang, Jinfan Zhang, Ziruo Zheng, Yuetian Pan, Wentao Gao & Yabin Yu. (2023) m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Hengzhao Zhuang, Bo Yu, Dan Tao, Xiaoyan Xu, Yijun Xu, Jian Wang, Yang Jiao & Lili Wang. (2023) The role of m6A methylation in therapy resistance in cancer. Molecular Cancer 22:1.
Crossref
Wei-Wei Liu, Zhong-Yuan Zhang, Fei Wang & Hao Wang. (2023) Emerging roles of m6A RNA modification in cancer therapeutic resistance. Experimental Hematology & Oncology 12:1.
Crossref
Yuanliang Yan, Jinwu Peng, Qiuju Liang, Xinxin Ren, Yuan Cai, Bi Peng, Xi Chen, Xiang Wang, Qiaoli Yi & Zhijie Xu. (2023) Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response. Genes & Diseases 10:1, pages 135-150.
Crossref
Zaoqu Liu, Haijiao Zou, Qin Dang, Hui Xu, Long Liu, Yuyuan Zhang, Jinxiang Lv, Huanyun Li, Zhaokai Zhou & Xinwei Han. (2022) Biological and pharmacological roles of m6A modifications in cancer drug resistance. Molecular Cancer 21:1.
Crossref
Zhen Fang, Wentong Mei, Chang Qu, Jiongdi Lu, Liang Shang, Feng Cao & Fei Li. (2022) Role of m6A writers, erasers and readers in cancer. Experimental Hematology & Oncology 11:1.
Crossref
Yangchan Li, Rui Su, Xiaolan Deng, Yong Chen & Jianjun Chen. (2022) FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends in Cancer 8:7, pages 598-614.
Crossref
Lin Yao, Chang-Feng Man, Rong He, Lian He, Jia-Bin Huang, Shou-Yan Xiang, Zhe Dai, Xiao-Yan Wang & Yu Fan. (2022) The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers. Frontiers in Oncology 11.
Crossref
Na Li, Xiaojuan Chen, Yanhong Liu, Tieming Zhou & Wei Li. (2021) Gene Characteristics and Prognostic Values of m6A RNA Methylation Regulators in Nonsmall Cell Lung Cancer. Journal of Healthcare Engineering 2021, pages 1-12.
Crossref